The Use of Borneol as an Enhancer for Targeting Aprotinin-Conjugated PEG-PLGA Nanoparticles to the Brain

Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration

(2012) Jungang Ren et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats

(2011) Huijuan He et al.   ARCHIVES OF PHARMACAL RESEARCH

Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration

(2011) Ziyi Wen et al.   JOURNAL OF CONTROLLED RELEASE

Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration

(2011) Yang Lu et al.   Journal of Zhejiang University-SCIENCE B

Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801-treated mice

(2011) Oguz Mutlu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System

(2010) Emanuela Fabiola Craparo et al.   CNS Neuroscience & Therapeutics

Recent advances in nanotechnology based drug delivery to the brain

(2010) Li-Na Lin et al.   CYTOTECHNOLOGY

Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro

(2010) Yongqiang Zhou et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect

(2010) Changyou Zhan et al.   JOURNAL OF CONTROLLED RELEASE

Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats

(2010) Chunyan Gao et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Aβ1-42 and Aβ25-35 peptides induce similar toxicity in organotypic hippocampal slice cultures and this effect can be prevented by resveratrol

(2009) Rudimar L. Frozza et al.   Alzheimers & Dementia

Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo

(2009) Rongqin Huang et al.   BRAIN RESEARCH BULLETIN

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

(2009) Bai-song Wang et al.   JOURNAL OF NEURAL TRANSMISSION

Blood-brain barrier alterations in ageing and dementia

(2009) Bogdan O. Popescu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Structure and function of the blood–brain barrier

(2009) N. Joan Abbott et al.   NEUROBIOLOGY OF DISEASE

Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer's disease

(2008) Armen A. Galoyan et al.   Alzheimers & Dementia

Fragrance material review on borneol

(2008) S.P. Bhatia et al.   FOOD AND CHEMICAL TOXICOLOGY

Pharmacokinetics of Huperzine A after transdermal and oral administration in beagle dogs

(2008) J.C. Ye et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations

(2008) Kaili Hu et al.   JOURNAL OF CONTROLLED RELEASE

Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration

(2008) Zheng Cai et al.   JOURNAL OF DRUG TARGETING

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2

(2008) Michel Demeule et al.   JOURNAL OF NEUROCHEMISTRY

LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-β peptide in a blood–brain barrier in vitro model

(2008) Babak Nazer et al.   NEUROBIOLOGY OF DISEASE